Back to Search
Start Over
Hemoperfusion during veno-venous ECMO in severe COVID-19 with IL-6 elevation.
- Source :
-
Cytokine . Apr2022, Vol. 152, pN.PAG-N.PAG. 1p. - Publication Year :
- 2022
-
Abstract
- • IL-6 might be a target of specific intervention in severe COVID-19. • Hemoperfusion and anti IL-6 drugs use have been reported in COVID-19 patients. • vv-ECMO support might worsen COVID-19-related cytokine release syndrome. • HA-380 hemoperfusion filter reduces IL-6 concentration. • Hemodynamic, renal and chest X ray improvement might be related to cytokines removal. [ABSTRACT FROM AUTHOR]
- Subjects :
- *HEMOPERFUSION
*INTERLEUKIN-6
*CHEST X rays
*CYTOKINE release syndrome
*COVID-19
Subjects
Details
- Language :
- English
- ISSN :
- 10434666
- Volume :
- 152
- Database :
- Academic Search Index
- Journal :
- Cytokine
- Publication Type :
- Academic Journal
- Accession number :
- 155697675
- Full Text :
- https://doi.org/10.1016/j.cyto.2022.155813